243 related articles for article (PubMed ID: 22062689)
1. Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution.
van de Ven AL; Kim P; Haley O; Fakhoury JR; Adriani G; Schmulen J; Moloney P; Hussain F; Ferrari M; Liu X; Yun SH; Decuzzi P
J Control Release; 2012 Feb; 158(1):148-55. PubMed ID: 22062689
[TBL] [Abstract][Full Text] [Related]
2. Investigation of silicon nanoparticles produced by centrifuge chemical vapor deposition for applications in therapy and diagnostics.
Lumen D; Wang S; Mäkilä E; Imlimthan S; Sarparanta M; Correia A; Westerveld Haug C; Hirvonen J; Santos HA; Airaksinen AJ; Filtvedt W; Salonen J
Eur J Pharm Biopharm; 2021 Jan; 158():254-265. PubMed ID: 33279602
[TBL] [Abstract][Full Text] [Related]
3. Membrane Radiolabelling of Exosomes for Comparative Biodistribution Analysis in Immunocompetent and Immunodeficient Mice - A Novel and Universal Approach.
Faruqu FN; Wang JT; Xu L; McNickle L; Chong EM; Walters A; Gurney M; Clayton A; Smyth LA; Hider R; Sosabowski J; Al-Jamal KT
Theranostics; 2019; 9(6):1666-1682. PubMed ID: 31037130
[TBL] [Abstract][Full Text] [Related]
4. Impact of surface grafting density of PEG macromolecules on dually fluorescent silica nanoparticles used for the in vivo imaging of subcutaneous tumors.
Adumeau L; Genevois C; Roudier L; Schatz C; Couillaud F; Mornet S
Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1587-1596. PubMed ID: 28179102
[TBL] [Abstract][Full Text] [Related]
5. Etoposide loaded solid lipid nanoparticles for curtailing B16F10 melanoma colonization in lung.
Athawale RB; Jain DS; Singh KK; Gude RP
Biomed Pharmacother; 2014 Mar; 68(2):231-40. PubMed ID: 24560352
[TBL] [Abstract][Full Text] [Related]
6. The fate of MAb-targeted Cd(125m)Te/ZnS nanoparticles in vivo.
Kennel SJ; Woodward JD; Rondinone AJ; Wall J; Huang Y; Mirzadeh S
Nucl Med Biol; 2008 May; 35(4):501-14. PubMed ID: 18482688
[TBL] [Abstract][Full Text] [Related]
7. Circulation kinetics and biodistribution of dual-labeled polymersomes with modulated surface charge in tumor-bearing mice: comparison with stealth liposomes.
Lee JS; Ankone M; Pieters E; Schiffelers RM; Hennink WE; Feijen J
J Control Release; 2011 Oct; 155(2):282-8. PubMed ID: 21820023
[TBL] [Abstract][Full Text] [Related]
8. The effect of nanoparticle properties, detection method, delivery route and animal model on poly(lactic-co-glycolic) acid nanoparticles biodistribution in mice and rats.
Simon LC; Sabliov CM
Drug Metab Rev; 2014 May; 46(2):128-41. PubMed ID: 24303927
[TBL] [Abstract][Full Text] [Related]
9.
Banerjee SR; Foss CA; Horhota A; Pullambhatla M; McDonnell K; Zale S; Pomper MG
Biomacromolecules; 2017 Jan; 18(1):201-209. PubMed ID: 28001364
[TBL] [Abstract][Full Text] [Related]
10. Preparation and in-vitro/in-vivo evaluation of surface-modified poly (lactide-co-glycolide) fluorescent nanoparticles.
Pamujula S; Hazari S; Bolden G; Graves RA; Chinta DM; Dash S; Kishore V; Mandal TK
J Pharm Pharmacol; 2010 Apr; 62(4):422-9. PubMed ID: 20604830
[TBL] [Abstract][Full Text] [Related]
11. In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: mechanisms, key factors, and their implications.
Cho YW; Park SA; Han TH; Son DH; Park JS; Oh SJ; Moon DH; Cho KJ; Ahn CH; Byun Y; Kim IS; Kwon IC; Kim SY
Biomaterials; 2007 Feb; 28(6):1236-47. PubMed ID: 17126900
[TBL] [Abstract][Full Text] [Related]
12. Negative-charge-functionalized mesoporous silica nanoparticles as drug vehicles targeting hepatocellular carcinoma.
Xie M; Xu Y; Shen H; Shen S; Ge Y; Xie J
Int J Pharm; 2014 Oct; 474(1-2):223-31. PubMed ID: 25149125
[TBL] [Abstract][Full Text] [Related]
13. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence imaging and targeted distribution of bacterial magnetic particles in nude mice.
Tang T; Zhang L; Gao R; Dai Y; Meng F; Li Y
Appl Microbiol Biotechnol; 2012 Apr; 94(2):495-503. PubMed ID: 22395909
[TBL] [Abstract][Full Text] [Related]
15. Chitosan microparticles and nanoparticles as biocompatible delivery vehicles for peptide and protein-based immunocontraceptive vaccines.
Chua BY; Al Kobaisi M; Zeng W; Mainwaring D; Jackson DC
Mol Pharm; 2012 Jan; 9(1):81-90. PubMed ID: 22149016
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
[TBL] [Abstract][Full Text] [Related]
17. Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats.
Bimbo LM; Sarparanta M; Santos HA; Airaksinen AJ; Mäkilä E; Laaksonen T; Peltonen L; Lehto VP; Hirvonen J; Salonen J
ACS Nano; 2010 Jun; 4(6):3023-32. PubMed ID: 20509673
[TBL] [Abstract][Full Text] [Related]
18. Size and shape effects in the biodistribution of intravascularly injected particles.
Decuzzi P; Godin B; Tanaka T; Lee SY; Chiappini C; Liu X; Ferrari M
J Control Release; 2010 Feb; 141(3):320-7. PubMed ID: 19874859
[TBL] [Abstract][Full Text] [Related]
19. Clinical scale synthesis of intrinsically radiolabeled and cyclic RGD peptide functionalized
Chakravarty R; Chakraborty S; Guleria A; Kumar C; Kunwar A; Nair KVV; Sarma HD; Dash A
Nucl Med Biol; 2019; 72-73():1-10. PubMed ID: 31255874
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region.
Amin M; Mansourian M; Koning GA; Badiee A; Jaafari MR; Ten Hagen TLM
J Control Release; 2015 Dec; 220(Pt A):308-315. PubMed ID: 26526970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
